ACORN CAPITAL ADVISORS, LLC
Top Portfolio Positions
18 positions ·
$285,787,755 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| TERN |
Terns Pharmaceuticals, Inc.
|
1,746,264 | $70,549,065 | 24.69% |
| CGON |
CG Oncology, Inc.
|
1,131,501 | $46,979,921 | 16.44% |
| URGN |
UroGen Pharma Ltd.
|
1,448,420 | $33,921,996 | 11.87% |
| TRVI |
Trevi Therapeutics, Inc.
|
2,144,844 | $26,853,446 | 9.40% |
| PBYI |
Puma Biotechnology, Inc.
|
4,131,299 | $24,581,229 | 8.60% |
| CADL |
Candel Therapeutics, Inc.
|
2,580,517 | $14,579,921 | 5.10% |
| HELP |
Cybin Inc.
|
1,573,023 | $12,867,328 | 4.50% |
| VSTM |
Verastem, Inc.
|
1,469,153 | $11,341,861 | 3.97% |
| BCAX |
Bicara Therapeutics Inc.
|
643,382 | $10,828,119 | 3.79% |
| TARA |
Protara Therapeutics, Inc.
|
1,752,115 | $9,338,772 | 3.27% |
Portfolio Trend
Holdings in CGON
Export CSVShares Held
Position Value (USD)
5 of 5 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $46,979,921 | 1,131,501 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,576,860 | 1,131,501 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $29,419,026 | 1,131,501 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,710,459 | 1,131,501 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $32,451,448 | 1,131,501 | Shares | Sole | 2025-05-19 | |
| No quarters match your search. | ||||||